Hyderabad: A joint study by the Centre for Cellular and Molecular Biology (CCMB) and L V Prasad Eye Institute (LVPEI) has ...
Researchers from the CSIR-Centre for Cellular and Molecular Biology (CCMB) and the LV Prasad Eye Institute have found alarming levels of antimicrobial resistance (AMR) in bacteria causing eye ...
Real world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase ...
NEW YORK CITY, NY / ACCESS Newswire / April 7, 2026 / New to The Street, one of the longest-running sponsored business ...
Longhorn Vaccines and Diagnostics (LHNVD), an IND enabling-stage biopharmaceutical company, today announced new preclinical ...
Neanderthals may have done more than just glue tools together with birch tar—they might have dabbed it on their wounds, too, ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial ...
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO), has granted a favourable recommendation for marketing permission of Wockhardt's novel antibiotic, Zaynich ...
A recent study shows how quickly germs teem on unwashed bedding. Here are 5 expert-approved steps to effectively kill those ...
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
A Belgian biotech company says it is advancing a novel approach to one of the world’s most dangerous drug‑resistant pathogens, as the World Health Organization issues new target product profiles for ...
The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, pneumonia and meningitis The World Health Organization (WHO) has published ...